Kairos Pharma, ENV-105, Carotuximab, Metastatic Castration-Resistant Prostate Cancer, mCRPC, Prostate Cancer, Phase 2, Clinical Trial, Interim Efficacy Data,

LOS ANGELES — October 6, 2026 Kairos Pharma, Ltd. announced positive and statistically significant interim efficacy data from its...